Hypermarcas To Sell Production Rights To MSD Brazil For $31 Million
This article was originally published in PharmAsia News
Executive Summary
Drug maker Hypermarcas said it would drop its agreement with Merck, Sharp & Dohme's Brazil unit to produce the drugs it markets in the country.